Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 692

1.

New developments in the understanding of immunology in silicosis.

Huaux F.

Curr Opin Allergy Clin Immunol. 2007 Apr;7(2):168-73. Review.

PMID:
17351471
2.

Basic pathogenetic mechanisms in silicosis: current understanding.

Rimal B, Greenberg AK, Rom WN.

Curr Opin Pulm Med. 2005 Mar;11(2):169-73. Review.

PMID:
15699791
3.

Type 2 immune response associated with silicosis is not instrumental in the development of the disease.

Misson P, Brombacher F, Delos M, Lison D, Huaux F.

Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L107-13. Epub 2006 Sep 22.

4.

Lymphocytes, lymphokines, and silicosis.

Davis GS, Holmes CE, Pfeiffer LM, Hemenway DR.

J Environ Pathol Toxicol Oncol. 2001;20 Suppl 1:53-65. Review.

PMID:
11570674
5.

The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis.

Migliaccio CT, Buford MC, Jessop F, Holian A.

J Leukoc Biol. 2008 Mar;83(3):630-9. Epub 2007 Dec 3.

PMID:
18056481
6.

Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles.

Barbarin V, Xing Z, Delos M, Lison D, Huaux F.

Am J Physiol Lung Cell Mol Physiol. 2005 May;288(5):L841-8. Epub 2004 Dec 17.

7.

Critical role of MARCO in crystalline silica-induced pulmonary inflammation.

Thakur SA, Beamer CA, Migliaccio CT, Holian A.

Toxicol Sci. 2009 Apr;108(2):462-71. doi: 10.1093/toxsci/kfp011. Epub 2009 Jan 16.

8.

Silica and the immune system.

Pernis B.

Acta Biomed. 2005;76 Suppl 2:38-44.

PMID:
16350548
9.

IgG subclass responses in experimental silicosis.

Weissman DN, Hubbs AF, Huang SH, Stanley CF, Rojanasakul Y, Ma JK.

J Environ Pathol Toxicol Oncol. 2001;20 Suppl 1:67-74.

PMID:
11570675
10.

Surfactant protein A prevents silica-mediated toxicity to rat alveolar macrophages.

Spech RW, Wisniowski P, Kachel DL, Wright JR, Martin WJ 2nd.

Am J Physiol Lung Cell Mol Physiol. 2000 Apr;278(4):L713-8.

11.

Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure.

Beamer CA, Holian A.

Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L186-95. Epub 2005 Apr 22.

12.

Tregs promote the differentiation of Th17 cells in silica-induced lung fibrosis in mice.

Song L, Weng D, Liu F, Chen Y, Li C, Dong L, Tang W, Chen J.

PLoS One. 2012;7(5):e37286. doi: 10.1371/journal.pone.0037286. Epub 2012 May 15.

13.

Chronic obstructive pulmonary disease and occupational exposure to silica.

Rushton L.

Rev Environ Health. 2007 Oct-Dec;22(4):255-72. Review.

PMID:
18351226
14.

Type I interferon signaling contributes to chronic inflammation in a murine model of silicosis.

Giordano G, van den Brûle S, Lo Re S, Triqueneaux P, Uwambayinema F, Yakoub Y, Couillin I, Ryffel B, Michiels T, Renauld JC, Lison D, Huaux F.

Toxicol Sci. 2010 Aug;116(2):682-92. doi: 10.1093/toxsci/kfq158. Epub 2010 May 31.

15.

IL-13 immunotoxin accelerates resolution of lung pathological changes triggered by silica particles in mice.

Ferreira TP, de Arantes AC, do Nascimento CV, Olsen PC, Trentin PG, Rocco PR, Hogaboam CM, Puri RK, Martins MA, Silva PM.

J Immunol. 2013 Nov 15;191(10):5220-9. doi: 10.4049/jimmunol.1203551. Epub 2013 Oct 16.

16.

Resistance to silica-induced lung fibrosis in senescent rats: role of alveolar macrophages and tumor necrosis factor-alpha (TNF).

Corsini E, Giani A, Peano S, Marinovich M, Galli CL.

Mech Ageing Dev. 2004 Feb;125(2):145-6.

PMID:
15037020
17.

Th17 can regulate silica-induced lung inflammation through an IL-1β-dependent mechanism.

Song L, Weng D, Dai W, Tang W, Chen S, Li C, Chen Y, Liu F, Chen J.

J Cell Mol Med. 2014 Sep;18(9):1773-84. doi: 10.1111/jcmm.12341. Epub 2014 Aug 5.

18.

Interleukin-12 is not essential for silicosis in mice.

Davis GS, Pfeiffer LM, Hemenway DR, Rincon M.

Part Fibre Toxicol. 2006 Jan 5;3:2.

19.

Silicosis and fibrogenesis: fact and artifact.

Reiser KM, Last JA.

Toxicology. 1979 May;13(1):51-72. Review.

PMID:
229587
20.

Diseases caused by silica: mechanisms of injury and disease development.

Ding M, Chen F, Shi X, Yucesoy B, Mossman B, Vallyathan V.

Int Immunopharmacol. 2002 Feb;2(2-3):173-82. Review.

PMID:
11811922
Items per page

Supplemental Content

Write to the Help Desk